Inventor · disambiguated record
John M. Lambert
Also filed as: LAMBERT JOHN · LAMBERT JOHN M
12 granted patents·3 pending applications·4,746 citations·filing 1984–2019
95Inventor score
Top patents by PatentIndex Score
15 records- 0199US4569789AAcid-cleavable compound, use in protein conjugates and drug delivery systemsDANA FARBER CANCER INST INC·Filed 1985·Granted Feb 11, 1986·458 cites·17 claims
- 0299US4542225AAcid-cleavable compoundDANA FARBER CANCER INST INC·Filed 1984·Granted Sep 17, 1985·107 cites·20 claims
- 0398US5416064ACytotoxic agents comprising maytansinoids and their therapeutic useIMMUNOGEN INC·Filed 1992·Granted May 16, 1995·1.3k cites·20 claims
- 0498US5208020ACytotoxic agents comprising maytansinoids and their therapeutic useIMMUNOGEN INC·Filed 1992·Granted May 4, 1993·2.4k cites·18 claims
- 0598US4625014ACell-delivery agentDANA FARBER CANCER INST INC·Filed 1984·Granted Nov 25, 1986·255 cites·28 claims
- 0698US4618492AAcid-cleavable compoundDANA FARBER CANCER INST INC·Filed 1985·Granted Oct 21, 1986·98 cites·6 claims
- 0796US4764368AAcid-cleavable compoundDANA FARBER CANCER INST INC·Filed 1986·Granted Aug 16, 1988·57 cites·20 claims
- 0890US8137669B2Elimination of heterogeneous or mixed cell population in tumorsGOLDMAKHER VIKTOR S·Filed 2008·Granted Mar 20, 2012·7 cites·5 claims
- 0988US8388960B2Elimination of heterogeneous or mixed cell population in tumorsGOLDMAKHER VIKTOR S·Filed 2011·Granted Mar 5, 2013·7 cites·3 claims
- 1080US5239062ABlocked lectins, methods and affinity support for making same using affinity ligands, and method of killing selected cell populations having reduced nonselective cytotoxicityDANA FARBER CANCER INST INC·Filed 1990·Granted Aug 24, 1993·43 cites·99 claims
- 1178US4888415AGelonin immunotoxinDANA FARBER CANCER INST INC·Filed 1988·Granted Dec 19, 1989·49 cites·10 claims
- 1267US5395924ABlocked lectins; methods and affinity support for making the same using affinity ligands; and method of killing selected cell populations having reduced non-selective cytotoxicityDANA FARBER CANCER INST INC·Filed 1993·Granted Mar 7, 1995·32 cites·18 claims
- 1364US2006233814A1Elimination of heterogeneous or mixed cell population in tumorsIMMUNOGEN INC·Filed 2006·Application pending·0 cites
- 1450US2021403594A1Epcam antibodies, activatable antibodies, and immunoconjugates, and uses thereofIMMUNOGEN INC·Filed 2019·Application pending·0 cites
- 1537US2019038762A1Gcc-targeted antibody-drug conjugatesMILLENNIUM PHARM INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John M. Lambert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →